Actinic keratosis
See also in: External and Internal Eye,Hair and ScalpAlerts and Notices
Synopsis

Actinic keratoses (AKs) are considered precancerous lesions and present as rough, scaly macules or patches arising on chronically sun-exposed skin. This is a very common condition in individuals with lighter skin colors and is virtually unseen in people with darker skin colors. AKs are commonly seen on sun-exposed skin of the face, ears, scalp (areas of hair loss), neck, upper chest, forearms, dorsal hands, shins, and, less commonly, the eyelids and periocular region. These flat, scaly papules are of varying sizes and usually begin as "rough" localized skin lesions that the patient feels but are difficult to see. They are usually asymptomatic but may be tender.
The frequency of AKs increases with age and cumulative lifetime sun exposure. They are also more common in individuals who are immunosuppressed (especially after solid organ transplantation) and in males. They may resolve with protection from ultraviolet (UV) light. Some medications (ie, capecitabine, sorafenib) may induce inflammation of existing AKs.
Patients with AKs are at higher risk for developing nonmelanoma skin cancer. AKs have the potential to evolve into squamous cell carcinoma (SCC). It is estimated that the likelihood that a given AK will evolve into an invasive SCC is approximately 0.075%-0.096% per lesion.
The term "field cancerization" is used to describe areas of skin at risk for both AK and SCC. Clinically, this manifests as numerous AKs and squamous cell carcinoma in situ (SCCis) with or without invasive SCCs in a field of chronically sun-damaged skin. Risk factors include male sex, lighter skin color, older age, underlying immunosuppression, and the degree of prior exposure to UV light.
Related topic: actinic cheilitis
The frequency of AKs increases with age and cumulative lifetime sun exposure. They are also more common in individuals who are immunosuppressed (especially after solid organ transplantation) and in males. They may resolve with protection from ultraviolet (UV) light. Some medications (ie, capecitabine, sorafenib) may induce inflammation of existing AKs.
Patients with AKs are at higher risk for developing nonmelanoma skin cancer. AKs have the potential to evolve into squamous cell carcinoma (SCC). It is estimated that the likelihood that a given AK will evolve into an invasive SCC is approximately 0.075%-0.096% per lesion.
The term "field cancerization" is used to describe areas of skin at risk for both AK and SCC. Clinically, this manifests as numerous AKs and squamous cell carcinoma in situ (SCCis) with or without invasive SCCs in a field of chronically sun-damaged skin. Risk factors include male sex, lighter skin color, older age, underlying immunosuppression, and the degree of prior exposure to UV light.
Related topic: actinic cheilitis
Codes
ICD10CM:
L57.0 – Actinic keratosis
SNOMEDCT:
201101007 – Actinic keratosis
L57.0 – Actinic keratosis
SNOMEDCT:
201101007 – Actinic keratosis
Look For
Subscription Required
Diagnostic Pearls
Subscription Required
Differential Diagnosis & Pitfalls
- Superficial basal cell carcinoma
- SCCis (Bowen disease)
- Psoriasis
- Flat wart
- Common wart
- Seborrheic dermatitis – Patients with significant seborrheic dermatitis will benefit from initial treatment of dermatitis before beginning treatment for AK.
- SCC
- Seborrheic keratosis
- Discoid lupus erythematosus
- Disseminated superficial actinic porokeratosis
- Severe xerosis – Wiping the skin with water or an alcohol pad will minimize background xerosis. In addition, xerosis lacks the classic gritty sensation on light palpation.
- Lentigo (pigmented variant)
- Lentigo maligna (pigmented variant)
Best Tests
Subscription Required
Management Pearls
Subscription Required
Therapy
Subscription Required
Drug Reaction Data
Below is a list of drugs with literature evidence indicating an adverse association with this diagnosis. The list is continually updated through ongoing research and new medication approvals. Click on Citations to sort by number of citations or click on Medication to sort the medications alphabetically.
Subscription Required
References
Subscription Required
Last Reviewed:12/18/2021
Last Updated:02/10/2022
Last Updated:02/10/2022

Premium Feature
VisualDx Patient Handouts
Available in the Elite package
- Improve treatment compliance
- Reduce after-hours questions
- Increase patient engagement and satisfaction
- Written in clear, easy-to-understand language. No confusing jargon.
- Available in English and Spanish
- Print out or email directly to your patient
Upgrade Today
Actinic keratosis
See also in: External and Internal Eye,Hair and Scalp